Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)

11.74 +0.26 (+2.31%)
Streaming Delayed Price Updated: 12:08 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,062,298
Open 11.55
Bid (Size) 11.74 (700)
Ask (Size) 11.75 (300)
Prev. Close 11.48
Today's Range 11.46 - 11.83
52wk Range 6.685 - 11.88
Shares Outstanding 1,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Value Stocks We Find Risky
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
Why Amneal (AMRX) Stock Is Up Today
Shares of pharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) jumped 8.9% in the afternoon session after the company reported strong third-quarter financial results that surpassed expectations... 
Via StockStory

Performance

YTD
+51.4%
+51.4%
1 Month
+20.5%
+20.5%
3 Month
+32.9%
+32.9%
6 Month
+54.5%
+54.5%
1 Year
+27.7%
+27.7%

More News

Read More
Amneal Pharmaceuticals Inc (NASDAQ:AMRX) Q3 2025 Earnings: EPS Beats Estimates, Stock Surges on Raised Guidance
Via Chartmill
Topics Earnings
Earnings Scheduled For October 30, 2025
Via Benzinga
Amneal (NASDAQ:AMRX) Beats Q3 Sales Expectations, Stock Soars
Via StockStory
Amneal Reports Third Quarter 2025 Financial Results
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
Amneal Earnings: What To Look For From AMRX
Via StockStory
Topics Artificial Intelligence
Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
3 Cash-Producing Stocks with Questionable Fundamentals
Via StockStory
3 of Wall Street’s Favorite Stocks We Find Risky
Via StockStory
Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs
Via Benzinga
Topics Government World Trade
1 Small-Cap Stock with Competitive Advantages and 2 We Turn Down
Via StockStory
Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab)
From Kashiv BioSciences, LLC and Amneal Pharmaceuticals, Inc. and Alvotech and Advanz Pharma
Via Business Wire
3 Lesser-Known Healthcare Names With Major Upside in Store
Via MarketBeat
Amneal to Report Third Quarter 2025 Results on October 30, 2025
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab)
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
Amneal Pharma Stock Rises On FDA Approval For Generic Version Of AbbVie’s Eyedrops
Via Stocktwits
Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01%
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
3 Low-Volatility Stocks We Find Risky
Via StockStory
Topics Economy Government World Trade
Why Amneal (AMRX) Stock Is Up Today
Via StockStory
Topics Artificial Intelligence Economy
Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
3 Hyped Up Stocks with Open Questions
Via StockStory
1 Cash-Producing Stock for Long-Term Investors and 2 We Turn Down
Via StockStory
Topics Bonds

Frequently Asked Questions

Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?
Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market
What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 11.74
When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 11/11/25 12:08 PM ET
What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 11.74K
How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Amneal Pharmaceuticals, Inc. - Class A Common Stock has 12K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.